# MILESTONE REPORT — M2.1: Founder Experience Polish
**Date:** 4 July 2026 · **Status:** ✅ Complete · **Tests:** 25/25 · **App:** boots clean from fresh DB, all features verified live

## Executive summary
All ten founder-experience changes shipped, with one constitutional amendment: nothing was allowed to fake intelligence to feel intelligent. Business DNA derives every trait from named evidence (Decision Speed comes from your stated sales cycle, not from vibes). Evidence counts are real counts. The analysis sequence paces the reveal of steps that genuinely happened. The product now *feels* like reasoning because it *is* reasoning.

## The ten changes — status
1. **Analysis sequence** ✅ Save & Diagnose triggers a staged full-screen reveal (Analyzing → Building Business Twin → … → done), ~5s, then lands on the diagnosis.
2. **Living Business Twin** ✅ Deterministic analyst-voice narrative opens the Twin. It names the company, its motion, contrasts strengths vs constraints ("…look healthy, but pricing & monetization and founder dependency are limiting revenue growth"), and — the best sentence in the product — flags when the founder's self-diagnosis disagrees with the evidence.
3. **Score provenance** ✅ Under the score: real counts — evidence points, audit answers, evidence citations, dimensions analyzed. Computed, not decorative.
4. **Confidence breakdown** ✅ "Diagnosis Confidence" with ✓ analyzed dimensions vs missing/future evidence (CRM records, financial data — labeled as arriving with the Evidence Engine).
5. **Questions AFK still has** ✅ Real audit gaps first, then constraint-specific probes ("When did you last quote a higher price to a brand-new prospect, and what happened?"). Max 5.
6. **Recommendation trust card** ✅ Action + Why + Evidence + Confidence % (with basis) + Assumptions (explicitly marked unvalidated) + Expected Impact.
7. **Executive Diagnosis** ✅ Renamed everywhere; Revenue Health lives inside it as the score. `#health` redirects.
8. **Business DNA** ✅ Six trait cards, each citing its source question; unknown traits say "Unknown — not enough evidence." (Risk Appetite dropped — no evidence for it; Decision Speed kept — derived from sales cycle.)
9. **What Changed** ✅ Diagnosis snapshots on every save; next visit shows score delta, improved/declined dimensions with real numbers, and constraint movement. Verified live: +13 (75→88), Pricing +40, Follow-up +35, constraint moved Pricing → Founder Dependency.
10. **Completion message** ✅ "We've built the first version of your Business Twin."

Philosophy note honored: the flow is Learn → Understand → Reason → Diagnose → Recommend → Improve → Learn Again — no "AI" anywhere in it. The engine is deterministic reasoning; the Analyst is optional on top.

## Engineering notes
- New: `DiagnosisSnapshot` model (history), M2.1 engine layer (narrative, DNA, provenance, open questions, recommendation).
- A mid-build file-duplication glitch created two parallel M2.1 implementations; resolved by keeping the stronger contract (org-named narrative, `known`/`source` DNA fields) and deleting the duplicate. All 25 tests green after consolidation.
- Frontend: `health.js` rewritten, `audit.js` sequence added, `twin.js` narrative+DNA, routes renamed.

## How to test (5 min)
Fresh unzip → `python run.py` → login `admin@afk.agency` / `password123`. You land on Executive Diagnosis. Read the Twin's Business Summary. Then: Audit → change pricing answers to strong ones → Save & Diagnose → watch the sequence → "We've built the first version of your Business Twin" → diagnosis now shows **Since your last diagnosis: +N** with the dimensions that moved.

## Risks / debt
- Narrative templates cover common paths well; unusual answer combinations may read stiff. Real-founder audits will surface which sentences need work.
- Analysis sequence is fixed-duration theater over instant computation — honest theater, but if we ever compute slower than the animation, sync them.
- Snapshot table grows one row per save; fine for years at this scale.

## Next: M3 — Evidence Engine (CRM + financial data as diagnosis evidence) — awaiting go.
